Novelix Pharmaceuticals Reports Strong Q2 FY27 Results with Net Profit Surging 193% YoY
Novelix Pharmaceuticals Ltd · Financial Result · 12 Nov 2026, 12:57 am
Novelix Pharmaceuticals Reports Strong Q2 FY27 Results with Net Profit Surging 193% YoY Novelix Pharmaceuticals posted standalone revenue from operations of ₹4,473.12 lakhs for the quarter ended 30th Sep'26, up 23.03% YoY from ₹3,635.89 lakhs and 21.18% QoQ from ₹3,691.39 lakhs. Net profit rose 193.23% YoY and 32.60% QoQ to ₹156.32 lakhs, compared to ₹53.31 lakhs in Q2 FY26. PBT surged to ₹186.62 lakhs versus ₹71.89 lakhs YoY. Basic and diluted EPS improved to ₹0.57 from ₹0.37 YoY. For H1 FY27, revenue reached ₹8,164.51 lakhs with net profit of ₹274.21 lakhs.
Original exchange filing (PDF)
More announcements from Novelix Pharmaceuticals Ltd
- Submission of Intimation of Corporate office opening. · 18 Nov 2026
- Submission of Supply agreement intimation. · 13 Nov 2026
- Submission of intimation of change in Designation of Director. · 12 Nov 2026
- Attached as per above Subject. · 12 Nov 2026
- Submission of outcome of the Board Meeting. · 12 Nov 2026
- Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve unaudited standalone .... · 11 Nov 2026
- Attached · 03 Oct 2026
- Attached · 02 Oct 2026
